Massimiliano Filosto

Flag of  |    +39 030 6729100 or +0039 030 3995632

Present Academic Role Prof. Filosto is Associate Professor of Neurology at the Department of Clinical and Experimental Sciences, University of Brescia. Present Clinical Role Prof. Filosto is Director of NeMO-Brescia Clinical Center, a Center of excellence for neuromuscular diseases affiliated with the ASST Spedali Civili of Brescia and the University of Brescia and part of the regional network for Rare Diseases. Education and Academic Training 1993: Degree in Medicine with honour, University of Catania 1999: Specialization in Neurology with honour, University of Verona 2003: Ph.D. in Neurosciences, University of Verona 2002-2003: Postdoctoral Research Fellow, Department of Neurology, Columbia University, New York, USA (Prof. S. DiMauro) Scientific Associations Since 2000 he is a member of the Italian Society of Neurology and the Italian Association of Myology; since 2005 of the Italian Association of Neuropathology; since 2007 of the World Muscle Society; since 2010 of the Italian Association for the Study of the Peripheral Nervous System. Since 2011 he is member of the Treat-NMD Neuromuscular Network. From 2012 to 2018 he was a member of the Board of the Italian Association of Myology (AIM). Since 2016 he is full Individual Member of the European Academy of Neurology (EAN) and participates to expert panels in neuromuscular diseases, neurogenetics, peripheral neuropathies and motor neuron diseases. Since 2021 he is FEAN, Fellow of the European Academy of Neurology. In 2021 he was elected as a member of the Management Group of the EAN Scientific Panel “Muscle & NMJ disorders” for the period 2022-2024. He is a member of the Medical/Scientific Commission of the Italian Amyotrophic Lateral Sclerosis Association (AISLA), Italian Union against Muscular Dystrophies (UILDM) and Mitocon Italia. Scientific Activity The main interests in the field of neurosciences are muscle, nerve and motor neuron diseases. His work focuses on metabolic myopathies, mainly on pathological findings, epigenetic and genetic aspects and genotype/phenotype relation in muscle glycogenosis and mitochondrial diseases. He also involved in studying etiological and pathogenetic aspects of ALS and inflammatory neuropathies. He is involved as a principal investigator in several national and international clinical studies and trials on neuromuscular diseases. He’s part of the Editorial Board of several scientific journals including Frontiers in Neurology, Frontiers in Neuroscience, Neurological Sciences, Acta Myologica and Journal of Clinical Medicine. He’s author- coauthor of more than 200 papers on PubMed-indexed international journals, eight book chapters, one book as an Editor and more than 300 abstracts for national and international congresses.

Healthcare Provider

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit